Finland-based entrepreneur and researcher focused on scalable AI and distributed systems, active in deep tech incubation, product strategy and developer tooling for machine learning. Tuomas Suomela brings experience bridging academic research and commercial products, advising startups and participating in seed to growth-stage investments. Market-relevant strengths include research-led product design, technical leadership, and ecosystem-building in Nordic and European AI markets.
Finland-based entrepreneur and researcher focused on scalable AI and distributed systems, active in deep tech incubation, product strategy and developer tooling for machine learning. Tuomas Suomela brings experience bridging academic research and commercial products, advising startups and participating in seed to growth-stage investments. Market-relevant strengths include research-led product design, technical leadership, and ecosystem-building in Nordic and European AI markets.
Adopts a research-driven, founder-friendly approach focused on scalable AI, distributed systems and developer tooling. Prefers seed to growth-stage deployments where technical differentiation and academic ties create durable moats. Emphasizes deep technical due diligence, capital efficiency and platform-level outcomes with multi-year horizons. Sources deals through Nordic/European networks and incubators, provides hands-on product and engineering guidance, and allocates follow-on capital selectively to accelerate commercialization and ecosystem adoption.
Adopts a research-driven, founder-friendly approach focused on scalable AI, distributed systems and developer tooling. Prefers seed to growth-stage deployments where technical differentiation and academic ties create durable moats. Emphasizes deep technical due diligence, capital efficiency and platform-level outcomes with multi-year horizons. Sources deals through Nordic/European networks and incubators, provides hands-on product and engineering guidance, and allocates follow-on capital selectively to accelerate commercialization and ecosystem adoption.
| Trades 917 | Longs Won 526/917 57% | Profit Factor 5.31 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.64M |
| Average Win $507,621.81 | Best Trade (Aug 28) $38.18M | Sharpe Ratio -9.43 |
| Average Loss -$128,527.82 | Worst Trade (Aug 02) -$3.2M | Z-Score 2.97 (99.7%) |
| Commissions $0 | Avg. Trade Length 8m 4w 1d | Expectancy $236,373.71 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,211 | 5,590 | 4,969 | 4,348 | 3,727 | 3,106 | 2,484 | 1,863 | 1,242 | 621 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 1,702 | $199,099.95 | $235,505.74 | - | $36,405.79 | 18.29% | -0.245% |
AAPL Apple Inc. | 141,057 | $30.95M | $43.57M | - | $12.62M | 40.77% | -7.354% |
ABBV AbbVie Inc. | 7,956 | $1.67M | $2M | - | $329,537.64 | 19.77% | -2.513% |
ABNB Airbnb, Inc. | 4,744 | $627,821.6 | $718,810.88 | - | $90,989.28 | 14.49% | -0.368% |
ABT Abbott Laboratories | 8,565 | $1.16M | $905,320.5 | - | -$259,605.24 | -22.29% | +0.085% |
ACGL Arch Capital Group Ltd | 5,847 | $532,369.35 | $587,798.91 | - | $55,429.56 | 10.41% | -0.603% |
ACN Accenture plc Class A | 24,931 | $6.75M | $4.14M | - | -$2.62M | -38.74% | +1.611% |
ADBE Adobe Inc. | 23,238 | $7.86M | $5.82M | - | -$2.04M | -25.95% | +1.013% |
ADI Analog Devices, Inc. | 7,837 | $1.87M | $2.88M | - | $1.01M | 54.36% | +0.202% |
ADP Automatic Data Processing Inc. | 877 | $270,467.11 | $233,685.41 | - | -$36,781.7 | -13.6% | +0.982% |
ADSK Autodesk, Inc. | 2,580 | $798,691.35 | $604,236 | - | -$194,455.35 | -24.35% | -0.328% |
AFL Aflac Inc. | 11,969 | $1.26M | $1.53M | - | $263,556.89 | 20.88% | +0.094% |
AJG Arthur J. Gallagher & Co. | 951 | $328,323.38 | $237,198.42 | - | -$91,124.96 | -27.75% | -2.745% |
ALL Allstate Corporation | 32,000 | $6.45M | $8.45M | - | $2M | 31.07% | -0.49% |
ALNY Alnylam Pharmaceuticals Inc | 1,235 | $333,474.56 | $253,817.2 | - | -$79,657.36 | -23.89% | +0.019% |
AMAT Applied Materials, Inc. | 20,000 | $4.49M | $10.15M | - | $5.67M | 126.27% | +1.176% |
AMD Advanced Micro Devices, Inc. | 25,743 | $4.35M | $12.26M | - | $7.91M | 182.05% | -1.904% |
AMGN Amgen Inc. | 2,272 | $634,365.23 | $875,083.52 | - | $240,718.29 | 37.95% | -0.64% |
AMP Ameriprise Financial, Inc. | 218 | $105,536.13 | $118,993.13 | - | $13,457 | 12.75% | +0.253% |
AMT American Tower Corporation | 13,691 | $2.52M | $2.37M | - | -$141,552.71 | -5.63% | -0.631% |